Sign in / Join Now
ETFs & Funds
- Transcept Pharmaceuticals Announces Purdue's Exercise of Option to Commercialize Intermezzo® in the US BW
Add a reply...
Latest StockTalks »
people get PRTK breaking news and analysis by email alert.
Get email alerts on PRTK »
Paratek Pharmaceuticals, Inc.
Get latest price
From other sites
Paratek, U.S. Department Of Defense Enter Research Agreement To Study Omadacycline Against Biodefense Pathogens
at TheStreet (Oct 11, 2016)
Paratek To Ring Nasdaq Closing Bell Recognizing 20th Anniversary
at TheStreet (Oct 4, 2016)
Paratek Pharmaceuticals, Inc. To Present At Two Upcoming Investor Conferences
at TheStreet (Sep 1, 2016)
Paratek Starts Final Stage Study Of Oral-only Omadacycline In ABSSSI
at Benzinga (Aug 15, 2016)
Paratek Initiates Phase 3 Study Of Oral-only Omadacycline In ABSSSI
at TheStreet (Aug 15, 2016)